Resources

Paige secures CE mark for prostate cancer detection solutions

US-based clinical-grade computational pathology solution provider Paige has secured CE mark for its Paige Prostate and Paige Insight solutions. Paige Prostate is a prostate cancer detection solution, while Paige Insight is an AI-powered digital pathology viewer that...

read more

Formlabs launches new dental business unit

3D printing company Formlabs has announced the creation of a new dental-focused business unit. Formlabs Dental will use the new Form 3B printer and its associated platform, which comes with a new range of dental materials, a dedicated service team and software to help...

read more

Invitae signs agreement to acquire Clear Genetics

US-based medical genetics firm Invitae has signed a definitive agreement to acquire Clear Genetics, a software developer, to provide genetic services, for a total consideration of approximately $50m. Under the agreement, Invitae will pay approximately $25m in cash and...

read more

Duodenoscopes: a dirty problem

Duodenoscopes are currently used in around 500,000 procedures a year in the US, and are essential tools for diagnosing and treating illnesses in the pancreas and bile ducts. The minimally invasive, re-usable fibreoptic devices are lowered into the upper part of the...

read more

Regenxbio sues FDA over gene therapy clinical hold

Regenxbio is taking the FDA to court over a clinical hold. The lawsuit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation of the regulatory action.

read more

Ode to Patients

Due to meetings in London on a Friday and in Dortmund on the following Monday, I spent the weekend in London.  As I walked the streets appreciating its history, I could not help but think of the history of medicine, as well.  Images of leeches and...

read more

Leave No Stone Unturned: A Pipeline Story

Building a leading gene therapy pipeline in under two years (and a lot of air miles): how to persevere and make the calls that matter. Throughout a career in business development I’ve sat at every seat at the negotiating table, but I count my experience building...

read more

With eyes on IPO, muscular dystrophy startup names new CEO

The scientific founder and CEO of Cambridge startup Dyne Therapeutics has hired a new CEO — a former CFO with experience in public stock offerings. Read more. The post With eyes on IPO, muscular dystrophy startup names new CEO appeared first on Atlas Venture.

read more

Early Company Evolution – People, Pipeline, and Purse

“Time flies when you’re having fun.” That’s how I feel as I reflect on the first three years of the growth of Kyn Therapeutics. So much has happened since my R&D colleague Michelle Zhang and I moved into the seed space at Atlas Venture (see...

read more